NO

Novanta IncNASDAQ NOVT Stock Report

Last reporting period 27 Sep, 2024

Updated 12 Nov, 2024

Last price

Market cap $B

6.36

Middle

Exchange

XNAS - Nasdaq

NOVT Stock Analysis

NO

Neutral

Based on Eyestock quantitative analysis, NOVT`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

52/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-15.3 %

Overvalued

Market cap $B

6.36

Dividend yield

Shares outstanding

35.741 B

Novanta, Inc. engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. The company is headquartered in Bedford, Massachusetts and currently employs 3,000 full-time employees. Its segments include Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures and markets photonics-based solutions, including laser scanning, laser beam delivery, carbon dioxide (CO2) laser, solid state laser, ultrafast laser, and optical light engine products to customers worldwide. The Vision segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators, pumps and related disposables; visualization solutions; wireless technologies, video recorder and video integration technologies. The Precision Motion segment designs, manufactures and markets optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles to customers worldwide.

View Section: Eyestock Rating